PubRank

Artur Schmidtchen

Author PubWeight™ 69.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol 2009 1.87
2 SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 2003 1.60
3 Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 2004 1.51
4 Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004 1.46
5 Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol 2011 1.44
6 Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 2006 1.30
7 Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 2005 1.28
8 Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008 1.25
9 Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog 2010 1.12
10 Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta 2007 1.12
11 Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 2005 1.11
12 Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 2008 1.11
13 Antimicrobial peptides derived from growth factors. Growth Factors 2007 1.09
14 End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One 2009 1.04
15 Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulin. Antioxid Redox Signal 2012 1.04
16 Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One 2011 1.02
17 C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules. J Biol Chem 2010 1.02
18 Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis. FEBS J 2006 1.00
19 Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Matrix Biol 2006 1.00
20 In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother 2006 0.97
21 Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur J Biochem 2003 0.96
22 Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog 2008 0.95
23 Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 2008 0.95
24 Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 2006 0.94
25 Histidine-rich glycoprotein exerts antibacterial activity. FEBS J 2007 0.94
26 Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir 2006 0.94
27 Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J 2006 0.94
28 Up-regulation of A1M/α1-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage. PLoS One 2011 0.93
29 Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood 2010 0.93
30 Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem 2010 0.92
31 Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One 2009 0.90
32 An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 2007 0.90
33 Protein C inhibitor--a novel antimicrobial agent. PLoS Pathog 2009 0.90
34 Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. Biochim Biophys Acta 2009 0.89
35 Structure-activity studies and therapeutic potential of host defense peptides of human thrombin. Antimicrob Agents Chemother 2011 0.89
36 SufA--a novel subtilisin-like serine proteinase of Finegoldia magna. Microbiology 2007 0.88
37 Thymic stromal lymphopoietin exerts antimicrobial activities. Exp Dermatol 2011 0.88
38 Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. Thromb Haemost 2004 0.88
39 Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 2006 0.88
40 Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis. PLoS One 2012 0.88
41 Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol 2003 0.86
42 Chemerin is an antimicrobial agent in human epidermis. PLoS One 2013 0.86
43 Proteolytic activation transforms heparin cofactor II into a host defense molecule. J Immunol 2013 0.85
44 Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol 2013 0.85
45 Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta 2006 0.84
46 Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm Venereol 2013 0.83
47 The C-terminal sequence of several human serine proteases encodes host defense functions. J Innate Immun 2011 0.83
48 Antimicrobial activity of peptides derived from human ß-amyloid precursor protein. J Pept Sci 2012 0.83
49 Antimicrobial C3a--biology, biophysics, and evolution. Adv Exp Med Biol 2007 0.82
50 Effects of clinical isolates of Pseudomonas aeruginosa on Staphylococcus epidermidis biofilm formation. FEMS Immunol Med Microbiol 2010 0.82
51 Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptides. Biochim Biophys Acta 2013 0.82
52 The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. PLoS Pathog 2013 0.82
53 Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochim Biophys Acta 2009 0.82
54 Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials 2009 0.81
55 Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity. PLoS One 2012 0.81
56 Membrane and lipopolysaccharide interactions of C-terminal peptides from S1 peptidases. Biochim Biophys Acta 2012 0.81
57 Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Derm Venereol 2003 0.80
58 SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation. Microbiology 2009 0.80
59 Gene expression demonstrates increased resilience toward harmful inflammatory stimuli in the proliferating epidermis of human skin wounds. Exp Dermatol 2010 0.80
60 The multiple faces of host defence peptides and proteins. J Innate Immun 2012 0.79
61 Cyclin A expression in chronic leg ulcers. Acta Derm Venereol 2006 0.79
62 Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes. J Biol Chem 2010 0.79
63 Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase. BMC Res Notes 2009 0.78
64 A descriptive study of bacterial load of full-thickness surgical wounds in dermatologic surgery. Dermatol Surg 2011 0.78
65 Binding and release of consensus peptides by poly(acrylic acid) microgels. Biomacromolecules 2009 0.78
66 Lipopolysaccharide interactions of C-terminal peptides from human thrombin. Biomacromolecules 2013 0.77
67 Effect of hydrophobicity on the interaction between antimicrobial peptides and poly(acrylic acid) microgels. J Phys Chem B 2010 0.77
68 Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen. Int J Pept 2011 0.77
69 Effects of peptide hydrophobicity on its incorporation in phospholipid membranes--an NMR and ellipsometry study. Biochim Biophys Acta 2010 0.76
70 p33 (gC1q receptor) prevents cell damage by blocking the cytolytic activity of antimicrobial peptides. J Immunol 2013 0.76
71 Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides. Biomacromolecules 2014 0.76
72 Mycosis Fungoides: A Retrospective Study of 44 Swedish Cases. Acta Derm Venereol 2016 0.76
73 Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. J Dermatol Sci 2008 0.75
74 The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation. J Immunol 2014 0.75
75 Effects of peptide secondary structure on the interaction with oppositely charged microgels. Biomacromolecules 2010 0.75
76 Need for Improved Definition of "Chronic Wounds" in Clinical Studies. Acta Derm Venereol 2017 0.75
77 A New Look for ActaDV with More Rapid Publication. Acta Derm Venereol 2017 0.75
78 Surgical site infections in dermatologic surgery: etiology, pathogenesis, and current preventative measures. Dermatol Surg 2015 0.75
79 Conformational aspects of high content packing of antimicrobial peptides in polymer microgels. ACS Appl Mater Interfaces 2017 0.75
80 Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia. Acta Derm Venereol 2015 0.75